PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

Misinformation About Titration: Mounjaro Zepbound Ozempic Wegovy Compound

Patient storyFitFlavorFun3,472 views13:38Jun 2024

Our summary

A patient talks about Ozempic doses and moving up. Also covers stopping and maintenance and the trials.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Introduction
  2. 0:06 Addressing misconceptions
  3. 3:29 Outdated information
  4. 5:58 The risk of rapid titration
  5. 8:53 Importance of research
  6. 12:23 Closing thoughts

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, Wegovy, Zepbound and Mounjaro
Who is speaking
Patient

Find more like it

Dose changeStopping and maintenanceThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV